FDAnews Drug Daily Bulletin

Oct. 25, 2012 | Vol. 9 No. 210

Congressional Probe Into Compounding Crisis Heats Up; GAO Investigation Sought

Two House Democrats asked the Government Accountability Office (GAO) to investigate the compounding pharmacy industry to look for gaps in federal and state oversight. Reps. John Tierney (Mass.) and Elijah Cummings (Md.) said they are concerned that other compounding pharmacies may have escaped regulatory scrutiny simply because they aren’t known to regulators.
Drug Industry Daily

Register Now
Print This Page
Email This Article
RSS
Archives

House Track-and-Trace Bill Moves to Floor Without Unit-Level Designs House Track-and-Trace Draft Leaves Unit Level Plan to FDA Senators Raise Alarm Over Hospital Pediatric Drug Shortages; FDA on the Case House Track-and-Trace Draft Leaves Unit Level Finagling to the FDA

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.